12th Bio-Pune Seminar Series: Symposium on Cancer Immunotherapy: Immune Checkpoint Inhibitors
Kindly note that this is a Tentative Outline and is subject to change
Potential gains |
|
Organized and Supported by |
|
For whom |
|
When | Saturday, June 24th 2017 Time: 8:30am – 6:30pm |
Where | Lecture Theatre, Venture Center, 900 NCL Innovation Park, Dr. Homi Bhabha Road, Pune-411008 |
Contact | Ms. Lipika Biswas, Venture Center Phone: +91-20-25865875/76/77 | Email: eventsdesk@venturecenter.co.in |
Registration Process/ Cost | Step 1: Interested participants need to fill in registration form at the following link. Note:
|
Introduction
Immunotherapy includes the use of antibodies, cancer vaccines or engineered immune cells that aid the immune system in specifically eliminating cancer cells. Clinical trials for a class of cancer immunotherapies known as Immune Checkpoint Inhibitors have shown significantly increased survival rates in patient with several types of malignant cancers. While selected ICIs have been approved for use in the US and EU, they have recently begun entering the Indian market.
The event will focus on Immune Checkpoint Inhibitors in the Indian Scenario and aim at understanding the following:
Event Outline
Event shall consist of:
Event includes
*Please note, the participants will have to arrange for their own travel/local transport and accommodation
and meals.
Tentative Event Schedule | ||
Time | Session title | Faculty |
8:30-9:00am | Registration : 900 Foyer Area | |
9:00-9:30am | Welcome and Introduction to the theme of the session: - About VC - About PCCM |
Dr. Premnath (Director, VC) Dr. C.B. Koppiker (Director, PCCM) |
9:30-10:15am | Keynote Lecture: Overview of Cancer Immunotherapy, Immune Checkpoints and Path forward |
Dr. Raju Titus Chacko (CMC, Vellore) |
10:15-10:45am | Session 1: Checkpoint Inhibition in Cancer - Basic Biology and Milestones in Discovery | To be decided |
10:45-11:15am | Session 2: Immune Checkpoint Therapy - Journey from Bench to Bedside | Dr. Raman Govindarajan (Sanofi, Bangalore) |
11:15-11:30am | Tea Break | |
Clinical Applications of Checkpoint Inhibitors | ||
11:30-12:00pm | Session 4: Clinical applications of checkpoint inhibitors – anti-PD-1 Therapeutics | Dr. Kumar Prabash (TMH, Mumbai) |
12:00-12:30pm | Session 5: Clinical applications of checkpoint inhibitors – anti-PDL-1 Therapeutics | Dr. Chetan Deshmukh (PCCM) |
12:30-1:30pm | Session 6: Panel Discussion | Chair : by Dr. Sudeep Gupta, Dy.Director ACTREC, Navi Mumbai |
1:30-2:15pm | Lunch Break | |
Diagnostics in Immune Checkpoint Therapy | ||
2:15-2:45pm | Session 7: Pathology Considerations | To be decided |
2:45-3:15pm | Session 8: Role of diagnostics in effective ICI Therapy | Dr. Shalu Verma (Core Diagnostics, Gurgaon) |
3:15-4:15pm | Session 9: Genomics Based Approaches for ICI Therapy | Dr. Aarti Desai (Affymetrix/ThermoFisher, Bangalore) |
4:15-4:45pm | Session 10: Liquid Biopsy Applications in ICI management | To be decided |
4:45pm –5:00pm | 15 min break | |
Regulatory Processes and Market Considerations | ||
5:00-5:30pm | Session 11: Regulatory Approval for ICI Therapeutics | Dr. Bangarurajan (CDSCO, Mumbai) or TBD? |
5:30-6:00pm | Session 12: ICI Therapy: Market Realities | To be decided |
6:00-6:30pm | Session 13: Investing in ICI: Potential areas for Innovation Entrepreneurship | Dr. Ajit Singh (Artiman Ventures, Palo Alto, CA, USA) |
6:30pm onwards | Mixer & Networking Dinner (By Invitation Only) |
About the Organizers
Entrepreneurship Development Center (Venture Center) – a CSIR initiative – is a
Section 25 company hosted by the National Chemical Laboratory, Pune. Venture
Center strives to nucleate and nurture technology and knowledge-based
enterprises by leveraging the scientific and engineering competencies of the
institutions in the Pune region in India. The Venture Center is a technology business
incubator supported by the Department of Science & Technology's National Science
& Technology Entrepreneurship Development Board (DST-NSTEDB). Venture
Center's focuses on technology enterprises offering products and services
exploiting scientific expertise in the areas of materials, chemicals and biological
sciences & engineering.
For more information, visit: http://www.venturecenter.co.in
Prashanti Cancer Care Mission (PCCM) is a registered, public charitable trust in
Pune. The trust works with the goal of providing affordable medical treatment to
cancer patients and undertaking medical education, training and research. PCCM
has established Orchids Breast Health Center (OBHC)-a Center of Affordable
Excellence for Breast Care- well-equipped with advanced cancer diagnostics,
chemotherapy day-care unit along-with expert Oncologists and allied healthcare
professionals. PCCM has been conferred with a Scientific and Industrial Research
Organization (SIRO) status by the Department of Scientific and Industrial Research
(DSIR) , Government of India. PCCM has also a member of the National Cancer Grid
Research Consortium of India co-ordinated by Tata Memorial Center, Mumbai.
For more information, visit: http://www.prashanticancercare.org